Explainer-Some patients reporting COVID rebounds after taking Pfizer pills

By Michael Erman (Reuters) - More than 2.8 million courses of Pfizer Inc's COVID-19 oral antiviral treatment Paxlovid have been made available at phar...

Related Keywords

United States ,American ,Mikael Dolsten ,William Pao ,Albert Bourla ,Caroline Humer ,Pfizer ,Us Centers For Disease ,Pfizer Inc ,Drug Administration ,Reuters ,Chief Development Officer William Pao ,Executive Albert Bourla ,Disease Control ,Michael Erman ,Bill Berkrot , ,